I sat down last week with ScaleReady's Global Director Commercial Operations, Josh Ludwig to get thoughts on the past 12 months and get some predictions for 2023.
I asked Josh...
• How was Phacilitates Advanced Therapies Week? 00:49
2022 Reflections
• Can you give me a quick overview of ScaleReady? 01:29
• One word to describe 2022 and why? 02:53
• What were some of ScaleReady's key achievements in 2022? 04:49
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 07:56
• Are there any areas you think the industry could improve? 10:28
2023 Forecasts
• What are your predictions for the Life Sciences and BioPharma in 2023? 12:53
• How will Sustainability and AI impact ATMP and Cell Therapy sector? 14:52
• What can we expect from ScaleReady in 2023? 20:04
• Will ScaleReady be looking for partners to cooperate with in 2023? 22:39
• Finally, what last thoughts would you like to leave viewers with for 2023? 25:14
🎞 WATCH the interview here https://lnkd.in/erpxwfUh
Feel free to leave Josh any comments and questions below.
You can meet Josh and the team at ScaleReady at numerous events throughout he year, including this months CAR-TCR Summit Europe at the Excel in London, and learn more at www.ScaleReady.com